Showing results (361-370 of 433) with videos related to

Sort By:
Pageof 44
Cardiovascular Research|March 24, 2025
Tetraspanin CD37 regulates platelet hyperreactivity and thrombosisMarcin A Sowa, Carmen Hannemann, Ivan Pinos, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|September 8, 2021
Mentoring Underrepresented Minority Physician-Scientists to SuccessAdina Kalet, Anne M Libby, Reshma Jagsi, et al.
Journal of the American College of Cardiology|January 19, 2026
Cardiovascular Risk Across Myocardial Injury and Infarction Categories Using the Universal Definition: An Individual Patient-Level Data Meta-AnalysisJasper Boeddinghaus, Pedro Lopez-Ayala, Alexander J F Thurston, et al.
Circulation. Cardiovascular Quality and Outcomes|November 14, 2019
Baseline Predictors of Low-Density Lipoprotein Cholesterol and Systolic Blood Pressure Goal Attainment After 1 Year in the ISCHEMIA TrialJonathan D Newman, Karen P Alexander, Xiangqiong Gu, et al.
Journal of the American Heart Association|March 9, 2022
Dialysis Initiation in Patients With Chronic Coronary Disease and Advanced Chronic Kidney Disease in ISCHEMIA-CKDCarlo Briguori, Roy O Mathew, Zhen Huang, et al.
Journal of the American College of Cardiology|July 19, 2023
Complete Revascularization and Angina-Related Health Status in the ISCHEMIA TrialKreton Mavromatis, Philip G Jones, Ziad A Ali, et al.
World Journal of Cardiology|October 2, 2010
Renal impairment and heart failure with preserved ejection fraction early post-myocardial infarctionVinod Jorapur, Gervasio A Lamas, Zygmunt P Sadowski, et al.
JAMA|November 7, 2002
Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trialA Michael Lincoff, Robert M Califf, Frans Van de Werf, et al.
Circulation. Cardiovascular Quality and Outcomes|March 1, 2012
Regional patterns of use of a medical management strategy for patients with non-ST-segment elevation acute coronary syndromes: insights from the EARLY ACS TrialMatthew T Roe, Jennifer A White, Padma Kaul, et al.
Critical Care Medicine|May 18, 2022
A Randomized Double-Blinded Placebo Controlled Trial of Clazakizumab for the Treatment of COVID-19 Pneumonia With HyperinflammationBonnie E Lonze, Peter Spiegler, Russell N Wesson, et al.
Pageof 44